Q1 2025 · 13F-HR
Column Group LLCholdings as filed
Filed 2025-05-14 · accession 0000950123-25-005219
$44.2M
Reported value
5
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $19.8M | 44.7% | 3,540,777 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $17.5M | 39.5% | 1,499,773 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $5.4M | 12.1% | 9,400,290 | Common | SOLE |
| 75382E109 | — | RAPT Therapeutics Inc | $1.6M | 3.67% | 1,328,613 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $1,627 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.